接受抗PD-1联合抗CTLA-4免疫治疗的黑色素瘤患者毒性反应季节性模式
该研究分析了三个中心(北半球和南半球)394例黑色素瘤患者的记录,患者至少接受一个周期抗PD-1/抗CTLA-4治疗且随访至少3个月。共记录764例免疫相关不良事件(irAEs),最常见为皮疹(35%)、肝炎(32%)和结肠炎(30%)。irAEs发生率在秋季和冬季最高,冬季每开始治疗对应的irAEs数量比值最高、夏季最低(分别为2.4和1.7)。
要点
- 共记录764例irAEs,最常见为皮疹(35%)、肝炎(32%)和结肠炎(30%)。
- irAEs发生率秋季和冬季最高,冬季每开始治疗对应irAEs数量比值最高、夏季最低(2.4 vs 1.7)。
- 肺炎秋季起病时间较短(p=0.025),肝炎春季起病时间较短(p=0.016),肉瘤样免疫反应秋季起病时间较短(p=0.041)。
核心结论
- 与特定季节相关的环境因素可能促进某些irAEs的发生,并提示环境触发因素的潜在作用。
- 识别这些因素可能增强预防和治疗策略,以降低irAEs的发病率。
研究设计与样本
- 回顾性分析三个中心(北半球和南半球)394例黑色素瘤患者的记录。
- 患者至少接受一个周期抗PD-1/抗CTLA-4治疗,随访至少3个月。
- 研究irAEs在日历年内的分布和起病时间。
主要发现
- 共记录764例irAEs,最常见为皮疹(35%)、肝炎(32%)和结肠炎(30%)。
- irAEs发生率秋季和冬季最高,冬季每开始治疗对应的irAEs数量比值最高、夏季最低(分别为2.4和1.7)。
- 肺炎秋季起病时间较短(p=0.025),肝炎春季起病时间较短(p=0.016),肉瘤样免疫反应秋季起病时间较短(p=0.041)。
- 早发性irAEs的季节性模式见于肝炎(春季,p=0.023)和肾炎(夏季,p=0.017)。
- 早发性肺炎在秋冬季更常见(p=0.008),早发性肾炎在春夏季更常见(p=0.004)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immune checkpoint inhibitors are frequently associated with the development of immunotherapy-related adverse events (irAEs). The exact etiology, including the role of environmental factors, remains incompletely understood. METHODS: We analyzed the records of 394 melanoma patients from three centers (northern and southern hemisphere). Patients had received at least one cycle of anti-PD-1/anti-CTLA-4 with a minimum follow-up of 3 months. We study the distribution and time to irAEs onset throughout the calendar year. RESULTS: 764 irAEs were recorded; the most frequent were skin rash (35%), hepatitis (32%) and colitis (30%). The irAEs incidence was the highest in autumn and winter, and the ratio for the 'number of irAEs' per 'therapies commenced' was the highest in winter and lowest in summer (2.4 and 1.7, respectively). Season-specific patterns in the time of irAEs onset were observed for pneumonitis (shorter time to onset in autumn, p = 0.025), hepatitis (shorter time to onset in spring, p = 0.016) and sarcoid-like immune reaction (shorter time to onset in autumn, p = 0.041). Season-specific patterns for early-onset irAEs were observed for hepatitis (spring, p = 0.023) and nephritis (summer, p = 0.017). Early-onset pneumonitis was more frequent in autumn-winter (p = 0.008) and early-onset nephritis in spring-summer (p = 0.004). CONCLUSIONS: Environmental factors that are associated with particular seasons may contribute to the development of certain irAEs and suggest the potential effect of environmental triggers. The identification of these factors may enhance preventive and therapeutic strategies to reduce the morbidity of irAEs.
引用
- Rogiers A, Dimitriou F, Lobon I, et al. Seasonal patterns of toxicity in melanoma patients treated with combination anti-PD-1 and anti-CTLA-4 immunotherapy. Eur J Cancer. 2023. PMID: 38184928. doi:10.1016/j.ejca.2023.113506
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。